Skip to content
Stock screener

DXCM Dexcom Inc stock chart & analysis

Conviction 47HealthcareScan · Fri, Nov 6, 2026

Dexcom Inc (DXCM) closed at $79.41 (-5.98%) on Nov 6, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 43, RS Rating 86, -14.2% from its 52-week high, +19.6% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.

DXCM$79.41-5.98%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Dexcom IncSurgical & Medical Instruments & Apparatuswww.dexcom.com ↗
Price79.41
Change-5.98%
Gap-2.38%
Rel volume1.02×
Avg volume5.12M
Avg $ vol419.95M
SMA 2082.72
SMA 5085.21
SMA 20074.88
Price vs 50-6.81%
Price vs 200+6.04%
MA stackmixed
50/200 cross—
Supertrendup · 77.87
RSI (14)43
MACD hist0.33
MACD crossbull · 4d
Stoch %K / %D21 / 58
ADX (14)17
+DI / −DI23 / 25
RSI divergence—
MACD divergence—
ATR %4.15%
ADR %3.59%
52w high92.59
52w low54.11
From 52w high-14.24%
Above 52w low+46.75%
New 52w highNo
SqueezeOff
Bollinger width16.43%
%B0.26
Donchian pos21.01%
Donchian high90.25
Donchian low76.52
AVWAP (52w high)85.03
vs AVWAP high-6.61%
AVWAP (52w low)72.19
vs AVWAP low+10.00%
OBV trendDown
Chaikin MF (20)-0.13
Today vs 20d1.02×
Avg vol (14d)5.79M
Avg vol (20d)5.12M
Avg $ vol (20d)419.95M
Market cap29.61B
RS Rating86 / 99
RS 3m (vs SPY)-4.54%
RS 6m (vs SPY)+31.31%
RS line new highNo
Trend template6/8
Technical rank68.6
1 week-3.51%
1 month-5.93%
3 months-9.41%
6 months+31.01%
1 year+33.95%
YTD+19.64%
P/E35.41
P/B11.68
P/S6.35
P/FCF27.49
EPS2.09
Div yield—
ROE32.98%
ROA13.40%
Debt/Eq0.00
Current1.74
EV/EBITDA24.63
Gross margin60.10%
Net margin17.94%
Rev growth15.60%
EPS growth45.14%
Price target99.56
Target upside25.38%
Analyst ratingBuy
Institutional118.26%
Ent. value28.66B
Revenue1.34B
Net income275.1M
Gross profit864.4M
Free cash flow1.08B
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNasdaq
Shares out385.87M
Employees11.1K
ListedThu, Apr 14, 2005
Free float384.41M
Float %99.6%
Short interest—
Days to cover—
Short volume66.7%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$0.73 vs $0.66
Last surprise+10.6% beat
Setup gradeD
Conviction47 / 100
Pattern quality—
Tech rank68.6 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance89.63
Support79.69
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

DXCM technical analysis

Trend

DXCM's moving averages are mixed — no clean uptrend or downtrend. It closed 6.8% below the 50-day ($85.21) and 6.0% above the 200-day ($74.88). ADX(14) at 17 points to a weak trend — more range than direction. It meets 6 of 8 trend-template criteria.

Momentum

RSI(14) is 43, in the bearish half of its range. MACD crossed above its signal line 4 sessions ago. Its RS Rating of 86 puts its weighted 12-month performance ahead of about 86% of the US market.

Volume and volatility

Volume on the latest session ran 1.0× its 20-day average. It trades about $420.0M a day on average. ATR(14) is $3.29, 4.2% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.13) shows distribution.

Key levels

The chart pattern's support is $79.69 and its resistance $89.63. The 52-week range is $54.11 to $92.59; price is 14.2% below the high and 46.8% above the low. The VWAP anchored at the 52-week high is $85.03, above price.

Performance

DXCM returned -3.5% (1 week), -5.9% (1 month), -9.4% (3 months), +31.0% (6 months), +34.0% (1 year), +19.6% (year to date).

About Dexcom Inc

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Surgical & Medical Instruments & Apparatus · Listed 2005 · 11,100 employees

Congress activity

Disclosed STOCK Act trades in DXCM · 10 recent

All disclosures →
MemberSideAmount
Tina Smith
Tina Smith
senate · D · MN · traded 2026-05-07
Sell$100K–$250K
Tina Smith
Tina Smith
senate · D · MN · traded 2026-04-29
Sell$100K–$250K
John Boozman
John Boozman
senate · R · AR · traded 2026-01-26
Buy$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-05-08
Buy$15K–$50K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-05-12
Sell$15K–$50K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Buy$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-04-07
Sell$15K–$50K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-04-08
Sell$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-02-25
Buy$1K–$15K
Kevin Hern
Kevin Hern
house · R · OK · traded 2024-12-31
Sell$50K–$100K

Insider activity

SEC Form 4 transactions in DXCM · open-market 5 sells

InsiderSideShares
Ashley Euan A.
Director · Common Stock · 2026-10-30
Gift2.39K
Stern Sadie
EVP Chief People & Culture Off · Common Stock · 2026-10-27
Sell2.56K
Brown Michael Jon
EVP Chief Legal Compliance Off · Common Stock · 2026-10-15
Sell1.7K
Stern Sadie
EVP Chief People & Culture Off · Common Stock · 2026-08-27
Sell2.56K
Brown Michael Jon
EVP Chief Legal Compliance Off · Common Stock · 2026-08-22
Tax1.45K
Stern Sadie
EVP Chief People & Culture Off · Common Stock · 2026-08-22
Tax1.45K
Sylvain Jereme M
EVP, Chief Financal Officer · Common Stock · 2026-08-22
Tax1.45K
Leach Jacob Steven
President, CEO, and Director · Common Stock · 2026-08-22
Tax1.45K
SAYER KEVIN R
Executive Chair · Common Stock · 2026-08-20
Sell19.31K
SAYER KEVIN R
Executive Chair · Common Stock · 2026-08-20
Sell7.35K

SEC filings

EDGAR filings in DXCM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.